معرفی
Andrew Dick is the Duke Elder Chair & Director of the Institute of Ophthalmology at University College London (UCL), and concurrently serves as Professor of Ophthalmology at the University of Bristol. He also co-directs the NIHR Biomedical Research Centre at Moorfields Eye Hospital and UCL-Institute of Ophthalmology. His medical training includes an MBBS and BSc (Hons) in Biochemistry from the University of London, followed by an MD from the University of Aberdeen.
Research Focus
Professor Dick's research centers on ocular immunology and inflammatory diseases, with seminal work on TNF-alpha's role in retinal inflammation and degeneration. His lab investigates macrophage plasticity, immune regulation (CD200R, C5aR, IRAK-M pathways), and develops biologic therapies for blinding diseases. His bench-to-bedside approach has revolutionized anti-TNF treatments for uveitis.
Publication Trends
Recent publications (2024-2025) demonstrate strong emphasis on: 1) Multimodal imaging guidelines for uveitis syndromes, 2) Genetic and machine learning approaches to retinal phenotyping, 3) Novel therapeutics including gene therapies and JAK inhibitors, and 4) Mechanisms of retinal degeneration involving Bruch's membrane and autophagy pathways.
Awards and Honors
- Fellow of Academy of Medical Sciences (2007)
- Alcon Research Institute Award (2011)
- Doyne Medal & Lecture
- Duke-Elder Lecture
- Constable Annual Public Lecture
- Certificate of Excellence (EVER)
- Golding Medal & Llewellyn Scholarship
Professional Leadership
Professor Dick has authored foundational textbooks (e.g., The Eye: Basic Science in Practice), chaired WHO uveitis classification committees, served as ARVO Vice-President and EVER President, and held editorial roles for major ophthalmology journals including Progress in Retinal and Eye Research.
